MTNB Competitors & Alternatives

Compare Matinas BioPharma Holdings Inc with similar stocks in the same industry

Biotechnology

MTNB

Main Stock
$0.80
-1.26%
Tradestie Score
52
Market Cap
$10.39M
Revenue Growth
-100.0%
Analyst Upside
+3650.5%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Delivery
Competitive Moat: None
Core Technology Stack: lipid nanocrystal (LNC) platform, encochleation technology
Major Customers 2
clinical research organizations research institutions
Critical Suppliers 2
lipid suppliers CROs
Direct Ecosystem Rivals 3

Top Competitors

216 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
EQ Equillium, Inc. Common Stock
$1.06
-5.36%
$88.06M - 47 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
VTVT vTv Therapeutics Inc. Class A Common Stock
$15.51
-5.20%
$62.81M - 46 Compare
DARE Dare Bioscience, Inc. Common Stock
$0.41
-9.86%
$28.98M - 42 Compare
OGEN Oragenics Inc.
$0.16
-8.72%
$5.86M - 31 Compare
TRVN TRVN
- - - - Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)

216 stocks in this industry